HEADER HYDROLASE/HYDROLASE INHIBITOR 21-SEP-08 3ELA TITLE CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA TITLE 2 MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VIIA LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: UNP RESIDUES 61-212; COMPND 5 EC: 3.4.21.21; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: COAGULATION FACTOR VIIA HEAVY CHAIN; COMPND 9 CHAIN: H; COMPND 10 FRAGMENT: UNP RESIDUES 213-466; COMPND 11 EC: 3.4.21.21; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: TISSUE FACTOR; COMPND 16 CHAIN: T; COMPND 17 FRAGMENT: UNP RESIDUES 33-241; COMPND 18 SYNONYM: TF, COAGULATION FACTOR III, THROMBOPLASTIN; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F7; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL: CHO-K1; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PEE-ACEDELTA36NJ; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: F7; SOURCE 17 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 20 EXPRESSION_SYSTEM_CELL: CHO-K1; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PEE-ACEDELTA36NJ; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 GENE: F3; SOURCE 28 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 30 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 31 EXPRESSION_SYSTEM_PLASMID: PET_TF1-209 KEYWDS SERINE PROTEASE, BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.BJELKE,M.FODJE,L.A.SVENSSON REVDAT 7 01-NOV-23 3ELA 1 REMARK REVDAT 6 10-NOV-21 3ELA 1 SEQADV HETSYN REVDAT 5 29-JUL-20 3ELA 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 25-OCT-17 3ELA 1 REMARK REVDAT 3 13-JUL-11 3ELA 1 VERSN REVDAT 2 24-FEB-09 3ELA 1 VERSN REVDAT 1 04-NOV-08 3ELA 0 JRNL AUTH J.R.BJELKE,O.H.OLSEN,M.FODJE,L.A.SVENSSON,S.BANG,G.BOLT, JRNL AUTH 2 B.B.KRAGELUND,E.PERSSON JRNL TITL MECHANISM OF THE CA2+-INDUCED ENHANCEMENT OF THE INTRINSIC JRNL TITL 2 FACTOR VIIA ACTIVITY JRNL REF J.BIOL.CHEM. V. 283 25863 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18640965 JRNL DOI 10.1074/JBC.M800841200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 32936 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1734 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 801 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.4770 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.5790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4119 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.13000 REMARK 3 B22 (A**2) : -2.32000 REMARK 3 B33 (A**2) : 4.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.283 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.242 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.237 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.241 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.909 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.839 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4280 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5840 ; 2.170 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 537 ;11.670 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;34.327 ;24.348 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 643 ;18.403 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;19.654 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 663 ; 0.134 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3252 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2118 ; 0.275 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2843 ; 0.319 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 325 ; 0.219 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.160 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 34 ; 0.526 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.308 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2751 ; 0.958 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4352 ; 1.667 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1747 ; 2.124 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1488 ; 3.171 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3ELA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34658 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 29.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.3 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 26.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.30 REMARK 200 R MERGE FOR SHELL (I) : 0.22900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.120 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP, CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1DAN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM NACITRATE, 16%(W/V) PEG4000, REMARK 280 12%(V/V) 1-PROPANOL, PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.27900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA L 1 REMARK 465 ASN L 2 REMARK 465 ALA L 3 REMARK 465 PHE L 4 REMARK 465 LEU L 5 REMARK 465 GLU L 6 REMARK 465 GLU L 7 REMARK 465 LEU L 8 REMARK 465 ARG L 9 REMARK 465 PRO L 10 REMARK 465 GLY L 11 REMARK 465 SER L 12 REMARK 465 LEU L 13 REMARK 465 GLU L 14 REMARK 465 ARG L 15 REMARK 465 GLU L 16 REMARK 465 CYS L 17 REMARK 465 LYS L 18 REMARK 465 GLU L 19 REMARK 465 GLU L 20 REMARK 465 GLN L 21 REMARK 465 CYS L 22 REMARK 465 SER L 23 REMARK 465 PHE L 24 REMARK 465 GLU L 25 REMARK 465 GLU L 26 REMARK 465 ALA L 27 REMARK 465 ARG L 28 REMARK 465 GLU L 29 REMARK 465 ILE L 30 REMARK 465 PHE L 31 REMARK 465 LYS L 32 REMARK 465 ASP L 33 REMARK 465 ALA L 34 REMARK 465 GLU L 35 REMARK 465 ARG L 36 REMARK 465 THR L 37 REMARK 465 LYS L 38 REMARK 465 LEU L 39 REMARK 465 PHE L 40 REMARK 465 TRP L 41 REMARK 465 ILE L 42 REMARK 465 SER L 43 REMARK 465 TYR L 44 REMARK 465 SER L 45 REMARK 465 ASP L 46 REMARK 465 GLY L 47 REMARK 465 LYS L 143 REMARK 465 ARG L 144 REMARK 465 ASN L 145 REMARK 465 ALA L 146 REMARK 465 SER L 147 REMARK 465 LYS L 148 REMARK 465 PRO L 149 REMARK 465 GLN L 150 REMARK 465 GLY L 151 REMARK 465 ARG L 152 REMARK 465 SER T 1 REMARK 465 GLY T 2 REMARK 465 THR T 3 REMARK 465 THR T 4 REMARK 465 ASN T 5 REMARK 465 LYS T 159 REMARK 465 SER T 160 REMARK 465 SER T 161 REMARK 465 SER T 162 REMARK 465 SER T 163 REMARK 465 GLY T 164 REMARK 465 LYS T 165 REMARK 465 ASP T 180 REMARK 465 LYS T 181 REMARK 465 GLY T 182 REMARK 465 GLU T 183 REMARK 465 ASN T 184 REMARK 465 TYR T 185 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS L 62 CG CD CE NZ REMARK 470 GLN L 66 CD OE1 NE2 REMARK 470 LEU L 73 CD1 CD2 REMARK 470 ASP L 104 OD2 REMARK 470 GLU L 132 OE1 REMARK 470 ASN H 173 CG OD1 ND2 REMARK 470 LYS H 197 CE NZ REMARK 470 LYS H 199 CB CG CD CE NZ REMARK 470 ASN H 200 CB CG OD1 ND2 REMARK 470 ARG H 202 CG CD NE CZ NH1 NH2 REMARK 470 ARG H 224 CG CD NE CZ NH1 NH2 REMARK 470 HIS H 249 CE1 NE2 REMARK 470 LEU H 254 CD1 REMARK 470 LEU H 288 CD1 CD2 REMARK 470 ARG H 290 CG CD NE CZ NH1 NH2 REMARK 470 ARG H 315 CG CD NE CZ NH1 NH2 REMARK 470 LYS H 316 CG CD CE NZ REMARK 470 ASP H 319 CB CG OD1 OD2 REMARK 470 LYS H 337 NZ REMARK 470 LYS H 341 CD CE NZ REMARK 470 GLU H 385 CD OE1 OE2 REMARK 470 LYS H 389 CG CD CE NZ REMARK 470 PHE H 405 CB REMARK 470 LYS T 15 NZ REMARK 470 THR T 21 O REMARK 470 LYS T 41 CG CD CE NZ REMARK 470 PRO T 92 O REMARK 470 GLU T 117 CG CD OE1 OE2 REMARK 470 LYS T 122 CD CE NZ REMARK 470 LYS T 149 CB CG CD CE NZ REMARK 470 TRP T 158 CE3 CZ2 CZ3 CH2 REMARK 470 LYS T 166 CD CE NZ REMARK 470 ARG T 200 CG CD REMARK 470 LYS T 201 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER H 344 C3 0Z6 H 407 1.68 REMARK 500 O HOH H 469 O HOH H 528 1.91 REMARK 500 CA GLY T 87 N ALA T 89 1.93 REMARK 500 CE1 HIS H 193 C3 0Z6 H 407 1.97 REMARK 500 OG SER H 344 O2 0Z6 H 407 2.06 REMARK 500 NZ LYS L 109 O HOH L 211 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS L 114 CB CYS L 114 SG -0.146 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER T 188 CB - CA - C ANGL. DEV. = -16.2 DEGREES REMARK 500 VAL T 189 N - CA - C ANGL. DEV. = 20.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER L 53 56.84 32.80 REMARK 500 ASN L 57 43.73 26.29 REMARK 500 SER L 67 -177.94 -170.30 REMARK 500 GLN L 100 -87.90 -124.41 REMARK 500 GLU L 116 134.13 -31.41 REMARK 500 LEU L 121 -168.01 -72.41 REMARK 500 VAL L 125 -55.33 -136.84 REMARK 500 ASN H 184 -168.63 -162.59 REMARK 500 SER H 190 -157.93 -128.89 REMARK 500 LYS H 199 -67.06 -106.61 REMARK 500 HIS H 211 -54.71 -161.13 REMARK 500 PRO H 236 128.48 -29.56 REMARK 500 THR H 272 -52.53 -120.19 REMARK 500 LEU H 297 125.34 -38.84 REMARK 500 ASP H 319 55.34 -157.64 REMARK 500 CYS H 340 -161.82 -125.12 REMARK 500 SER H 344 132.38 -37.38 REMARK 500 ARG H 353 79.18 -40.39 REMARK 500 SER H 363 -67.36 -138.05 REMARK 500 ILE H 384 -44.46 -27.80 REMARK 500 PRO H 395 128.40 -38.27 REMARK 500 PHE T 19 -4.64 84.01 REMARK 500 ASP T 66 100.89 -171.26 REMARK 500 ALA T 80 93.31 -56.40 REMARK 500 SER T 85 132.15 104.78 REMARK 500 THR T 86 -152.76 132.73 REMARK 500 SER T 88 50.27 -12.39 REMARK 500 ALA T 89 44.61 111.32 REMARK 500 GLU T 91 126.83 62.61 REMARK 500 PHE T 116 13.23 -148.48 REMARK 500 ASN T 138 -13.23 77.32 REMARK 500 LYS T 149 22.35 -72.53 REMARK 500 THR T 172 -178.23 127.08 REMARK 500 ASN T 173 60.21 -111.95 REMARK 500 SER T 195 5.77 -67.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY H 218 ASP H 219 -113.91 REMARK 500 TYR H 352 ARG H 353 -112.56 REMARK 500 GLY T 81 ASN T 82 130.21 REMARK 500 ASN T 82 VAL T 83 98.85 REMARK 500 VAL T 83 GLU T 84 110.69 REMARK 500 GLU T 84 SER T 85 84.76 REMARK 500 SER T 85 THR T 86 125.35 REMARK 500 THR T 86 GLY T 87 -61.55 REMARK 500 GLY T 87 SER T 88 31.06 REMARK 500 SER T 88 ALA T 89 98.24 REMARK 500 GLY T 90 GLU T 91 129.28 REMARK 500 SER T 188 VAL T 189 142.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS D-PHE-PHE-ARG- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 344 H FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 193 H REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 GLC L 215 REMARK 610 FUC L 216 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H 1 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 210 OE1 REMARK 620 2 ASP H 212 O 76.6 REMARK 620 3 GLU H 215 O 139.2 67.1 REMARK 620 4 GLU H 220 OE2 108.7 148.9 94.2 REMARK 620 5 HOH H 468 O 77.2 69.6 73.3 81.5 REMARK 620 6 HOH H 484 O 89.3 101.0 114.7 109.6 165.0 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PHENYLALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0Z6 H 407 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DPN PHE AR7 0QE REMARK 630 DETAILS: NULL DBREF 3ELA L 1 152 UNP P08709 FA7_HUMAN 61 212 DBREF 3ELA H 153 406 UNP P08709 FA7_HUMAN 213 466 DBREF 3ELA T 1 209 UNP P13726 TF_HUMAN 33 241 SEQADV 3ELA ASP H 158 UNP P08709 VAL 218 ENGINEERED MUTATION SEQADV 3ELA VAL H 296 UNP P08709 GLU 356 ENGINEERED MUTATION SEQADV 3ELA GLN H 298 UNP P08709 MET 358 ENGINEERED MUTATION SEQRES 1 L 152 ALA ASN ALA PHE LEU GLU GLU LEU ARG PRO GLY SER LEU SEQRES 2 L 152 GLU ARG GLU CYS LYS GLU GLU GLN CYS SER PHE GLU GLU SEQRES 3 L 152 ALA ARG GLU ILE PHE LYS ASP ALA GLU ARG THR LYS LEU SEQRES 4 L 152 PHE TRP ILE SER TYR SER ASP GLY ASP GLN CYS ALA SER SEQRES 5 L 152 SER PRO CYS GLN ASN GLY GLY SER CYS LYS ASP GLN LEU SEQRES 6 L 152 GLN SER TYR ILE CYS PHE CYS LEU PRO ALA PHE GLU GLY SEQRES 7 L 152 ARG ASN CYS GLU THR HIS LYS ASP ASP GLN LEU ILE CYS SEQRES 8 L 152 VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SER ASP SEQRES 9 L 152 HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS GLU GLY SEQRES 10 L 152 TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR PRO THR SEQRES 11 L 152 VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU GLU LYS SEQRES 12 L 152 ARG ASN ALA SER LYS PRO GLN GLY ARG SEQRES 1 H 254 ILE VAL GLY GLY LYS ASP CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 VAL LEU GLN VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 T 209 SER GLY THR THR ASN THR VAL ALA ALA TYR ASN LEU THR SEQRES 2 T 209 TRP LYS SER THR ASN PHE LYS THR ILE LEU GLU TRP GLU SEQRES 3 T 209 PRO LYS PRO VAL ASN GLN VAL TYR THR VAL GLN ILE SER SEQRES 4 T 209 THR LYS SER GLY ASP TRP LYS SER LYS CYS PHE TYR THR SEQRES 5 T 209 THR ASP THR GLU CYS ASP LEU THR ASP GLU ILE VAL LYS SEQRES 6 T 209 ASP VAL LYS GLN THR TYR LEU ALA ARG VAL PHE SER TYR SEQRES 7 T 209 PRO ALA GLY ASN VAL GLU SER THR GLY SER ALA GLY GLU SEQRES 8 T 209 PRO LEU TYR GLU ASN SER PRO GLU PHE THR PRO TYR LEU SEQRES 9 T 209 GLU THR ASN LEU GLY GLN PRO THR ILE GLN SER PHE GLU SEQRES 10 T 209 GLN VAL GLY THR LYS VAL ASN VAL THR VAL GLU ASP GLU SEQRES 11 T 209 ARG THR LEU VAL ARG ARG ASN ASN THR PHE LEU SER LEU SEQRES 12 T 209 ARG ASP VAL PHE GLY LYS ASP LEU ILE TYR THR LEU TYR SEQRES 13 T 209 TYR TRP LYS SER SER SER SER GLY LYS LYS THR ALA LYS SEQRES 14 T 209 THR ASN THR ASN GLU PHE LEU ILE ASP VAL ASP LYS GLY SEQRES 15 T 209 GLU ASN TYR CYS PHE SER VAL GLN ALA VAL ILE PRO SER SEQRES 16 T 209 ARG THR VAL ASN ARG LYS SER THR ASP SER PRO VAL GLU SEQRES 17 T 209 CYS HET GLC L 215 11 HET FUC L 216 10 HET CA H 1 1 HET 0Z6 H 407 34 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM 0Z6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO) HETNAM 2 0Z6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L- HETNAM 3 0Z6 PHENYLALANINAMIDE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN 0Z6 FFRCK FORMUL 4 GLC C6 H12 O6 FORMUL 5 FUC C6 H12 O5 FORMUL 6 CA CA 2+ FORMUL 7 0Z6 C25 H36 CL N6 O3 1+ FORMUL 8 HOH *214(H2 O) HELIX 1 1 ASP L 48 SER L 53 5 6 HELIX 2 2 ASP L 86 GLN L 88 5 3 HELIX 3 3 GLU L 94 CYS L 98 5 5 HELIX 4 4 ILE L 138 GLU L 142 5 5 HELIX 5 5 ALA H 192 ASP H 196 5 5 HELIX 6 6 GLU H 265 THR H 272 1 8 HELIX 7 7 LEU H 273 VAL H 276 5 4 HELIX 8 8 MET H 306 GLN H 313 1 8 HELIX 9 9 TYR H 383 SER H 393 1 11 HELIX 10 10 LEU T 59 VAL T 64 1 6 HELIX 11 11 THR T 101 THR T 106 1 6 HELIX 12 12 SER T 142 GLY T 148 1 7 SHEET 1 A 2 SER L 60 ASP L 63 0 SHEET 2 A 2 TYR L 68 PHE L 71 -1 O PHE L 71 N SER L 60 SHEET 1 B 2 PHE L 76 GLU L 77 0 SHEET 2 B 2 THR L 83 HIS L 84 -1 O THR L 83 N GLU L 77 SHEET 1 C 2 TYR L 101 HIS L 105 0 SHEET 2 C 2 THR L 108 ARG L 113 -1 O SER L 111 N SER L 103 SHEET 1 D 2 TYR L 118 LEU L 120 0 SHEET 2 D 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SHEET 1 E 8 LYS H 157 ASP H 158 0 SHEET 2 E 8 GLN H 298 LEU H 305 -1 O VAL H 299 N LYS H 157 SHEET 3 E 8 MET H 327 ALA H 330 -1 O CYS H 329 N LEU H 305 SHEET 4 E 8 GLY H 375 ARG H 379 -1 O GLY H 375 N ALA H 330 SHEET 5 E 8 THR H 355 TRP H 364 -1 N TRP H 364 O VAL H 376 SHEET 6 E 8 PRO H 347 TYR H 352 -1 N TYR H 352 O THR H 355 SHEET 7 E 8 PHE H 278 GLY H 283 -1 N LEU H 280 O ALA H 349 SHEET 8 E 8 GLN H 298 LEU H 305 -1 O GLN H 298 N GLY H 283 SHEET 1 F 8 LEU H 400 LEU H 401 0 SHEET 2 F 8 GLN H 221 ILE H 229 1 N VAL H 228 O LEU H 401 SHEET 3 F 8 ALA H 244 LEU H 248 -1 O ARG H 247 N ALA H 226 SHEET 4 F 8 TRP H 187 SER H 190 -1 N VAL H 188 O LEU H 246 SHEET 5 F 8 ALA H 175 ASN H 184 -1 N THR H 181 O VAL H 189 SHEET 6 F 8 GLN H 167 VAL H 172 -1 N LEU H 170 O CYS H 178 SHEET 7 F 8 LEU H 204 LEU H 208 -1 O VAL H 207 N LEU H 169 SHEET 8 F 8 GLN H 221 ILE H 229 -1 O GLN H 221 N LEU H 208 SHEET 1 G 3 TYR T 10 TRP T 14 0 SHEET 2 G 3 LEU T 23 GLU T 26 -1 O GLU T 26 N TYR T 10 SHEET 3 G 3 GLU T 56 CYS T 57 -1 O CYS T 57 N LEU T 23 SHEET 1 H 4 LYS T 46 THR T 52 0 SHEET 2 H 4 GLN T 32 THR T 40 -1 N VAL T 36 O LYS T 48 SHEET 3 H 4 TYR T 71 PRO T 79 -1 O ARG T 74 N GLN T 37 SHEET 4 H 4 TYR T 94 ASN T 96 -1 O GLU T 95 N VAL T 75 SHEET 1 I 3 ILE T 113 SER T 115 0 SHEET 2 I 3 LYS T 122 VAL T 127 -1 O THR T 126 N SER T 115 SHEET 3 I 3 GLN T 118 VAL T 119 -1 N VAL T 119 O LYS T 122 SHEET 1 J 3 ILE T 113 SER T 115 0 SHEET 2 J 3 LYS T 122 VAL T 127 -1 O THR T 126 N SER T 115 SHEET 3 J 3 PHE T 175 ASP T 178 -1 O PHE T 175 N VAL T 125 SHEET 1 K 3 THR T 167 THR T 170 0 SHEET 2 K 3 ILE T 152 TYR T 156 -1 N TYR T 153 O THR T 170 SHEET 3 K 3 VAL T 189 VAL T 192 -1 O VAL T 192 N ILE T 152 SSBOND 1 CYS L 50 CYS L 61 1555 1555 2.05 SSBOND 2 CYS L 55 CYS L 70 1555 1555 2.02 SSBOND 3 CYS L 72 CYS L 81 1555 1555 2.05 SSBOND 4 CYS L 91 CYS L 102 1555 1555 2.03 SSBOND 5 CYS L 98 CYS L 112 1555 1555 2.02 SSBOND 6 CYS L 114 CYS L 127 1555 1555 2.08 SSBOND 7 CYS L 135 CYS H 262 1555 1555 2.05 SSBOND 8 CYS H 159 CYS H 164 1555 1555 2.07 SSBOND 9 CYS H 178 CYS H 194 1555 1555 2.03 SSBOND 10 CYS H 310 CYS H 329 1555 1555 2.03 SSBOND 11 CYS H 340 CYS H 368 1555 1555 2.04 SSBOND 12 CYS T 49 CYS T 57 1555 1555 2.09 SSBOND 13 CYS T 186 CYS T 209 1555 1555 2.03 LINK NE2 HIS H 193 C3 0Z6 H 407 1555 1555 1.41 LINK OG SER H 344 C2 0Z6 H 407 1555 1555 1.49 LINK CA CA H 1 OE1 GLU H 210 1555 1555 2.23 LINK CA CA H 1 O ASP H 212 1555 1555 2.75 LINK CA CA H 1 O GLU H 215 1555 1555 2.56 LINK CA CA H 1 OE2 GLU H 220 1555 1555 2.50 LINK CA CA H 1 O HOH H 468 1555 1555 2.58 LINK CA CA H 1 O HOH H 484 1555 1555 2.31 CISPEP 1 PHE H 405 PRO H 406 0 0.66 CISPEP 2 GLU T 26 PRO T 27 0 1.88 CRYST1 78.361 68.558 78.817 90.00 90.22 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012761 0.000000 0.000049 0.00000 SCALE2 0.000000 0.014586 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012688 0.00000